Study of skin features, laboratory features and response to treatment to antifungal drugs in patients with superficial fungal infections.
Not Applicable
- Conditions
- Health Condition 1: null- EXTENSIVE DERMATOPHYTIC INFECTIONS
- Registration Number
- CTRI/2018/04/013045
- Lead Sponsor
- MAHARAJAHS INSTITUTE OF MEDICAL SCIENCES
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Clinically diagnosed cases of extensivedermatophytoses infection affecting more than one region of the body.
2. Both sexes between the age groups 18 - 70 yrs
3.Patients who have not used topical and systemic antifungal drugs for the past 6 weeks.
Exclusion Criteria
1.Infants, below 18 yrs, above 70 yrs
2.Immunocompromised patients including HIV are excluded.
3.Pregnancy and lactating patients are excludued.
4.Patients receiving multiple drugs for medical conditions including glucocorticosteroids.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Cinical profile of dermatophytic infections prevalent in this region will be noted. <br/ ><br>2.Mycological profile of dermatophytic infections including species identification prevalent in this region will be noted. <br/ ><br>3.Sensitivity pattern of isolates against terbinafine, itraconazole,griseofulvin will be studied and recorded. <br/ ><br>4.Therapeutic efficacy of single and in combinations of systemic antifungal drugs in extensive dermatophytic infections will be reported. <br/ ><br> <br/ ><br>Timepoint: 8 weeks <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. To note the recurrences in the follow up period of 6 months.Timepoint: 6 months